Age-related differences in white matter integrity and cognitive function are related to APOE status

NeuroImage

Volumn 54, Issue 2, 2011, Pages 1565-1577

  Ryan, Lee ^a   Walther, Katrin ^a   Bendlin, Barbara B ^b   Lue, Lih Fen ^c   Walker, Douglas G ^c   Glisky, Elizabeth L ^a  

^a University of Arizona   (United States)

^b WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

^c SUN HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

Aging; APOE; Cognition; Diffusion tensor imaging

Indexed keywords

APOLIPOPROTEIN E4;

ADULT; AGE; AGED; ARTICLE; BRAIN FUNCTION; BRAIN REGION; COGNITION; CONTROLLED STUDY; CORPUS CALLOSUM; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; FEMALE; FRACTIONAL ANISOTROPY; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN EXPERIMENT; MALE; MEMORY CONSOLIDATION; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; SCORING SYSTEM; TEMPORAL LOBE; VOLUNTEER; WHITE MATTER;

AGED; AGED, 80 AND OVER; AGING; ANISOTROPY; APOLIPOPROTEIN E4; BRAIN; COGNITION; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; POLYMERASE CHAIN REACTION;

EID: 78649660782     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2010.08.052     Document Type: Article

References (110)

1. Abe O., Yamasue H., Aoki S., Suga M., Yamada H., Kasai K., Masutani Y., Kato N., Kato N., Ohtomo K. Aging in the CNS: comparison of gray/white matter volume and diffusion tensor data. Neurobiol. Aging 2008, 29:102-116.
2. Adamson M.M., Landy K.M., Duong S., Fox-Bosetti S., Ashford J.W., Murphy G.M., Weiner M., Taylor J.L. Apolipoprotein E epsilon4 influences on episodic recall and brain structures in aging pilots. Neurobiol. Aging 2008, 10.1016/j.neurobiolaging.2008.07.017.
3. ADAPT Research Group, Lyketsos C.G., Breitner J.C., Green R.C., Martin B.K., Meinert C., Piantadosi S., Sabbagh M. Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial. Neurology 2007, 68:1800-1808.
4. Aisen P.S., Schmeidler J., Pasinetti G.M. Randomized pilot study of nimesulide treatment in Alzheimer's disease. Neurology 2002, 58:1050-1054.
5. Aisen P.S., Schafer K.A., Grundman M., Pfeiffer E., Sano M., Davis K.L., Farlow M.R., Jin S., Thomas R.G., Thal L.J. Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial. JAMA 2003, 289:2819-2826.
6. Bäckman L., Jones S., Berger A.K., Laukka E.J., Small B.J. Cognitive impairment in preclinical Alzheimer's disease: a meta-analysis. Neuropsychology 2005, 19:520-531.
7. Bartzokis G. Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer's disease. Neurobiol. Aging 2004, 25:5-18.
8. Bendlin B.B., Ries M.L., Canu E., Lazar M., Alexander A.L., Carlsson C.M., Sager M.A., Asthana S., Johnson S.C. White matter is altered with parental family history of Alzheimer's disease. Alzheimers Dement 2010, 6:394-403.
9. Bhagat Y.A., Beaulieu C. Diffusion anisotropy in subcortical white matter and cortical gray matter: changes with aging and the role of CSF-suppression. J. Magn. Reson. Imaging 2004, 20:216-227.
10. Blair C.K., Folsom A.R., Knopman D.S., Bray M.S., Mosley T.H., Boerwinkle E., Atherosclerosis Risk in Communities (ARIC) Study Investigators APOE genotype and cognitive decline in a middle-aged cohort. Neurology 2005, 64:268-276.
11. Bozzali M., Falini A., Franceschi M., Cercignani M., Zuffi M., Scotti G., Comi G., Filippi M. White matter damage in Alzheimer's disease assessed in vivo using diffusion tensor magnetic resonance imaging. J. Neurol. Neurosurg. Psychiatry 2002, 72:742-746.
12. Bretsky P., Guralnik J.M., Launer L., Albert M., Seeman T.E. The role of APOE-epsilon4 in longitudinal cognitive decline: MacArthur Studies of Successful Aging. Neurology 2003, 60:1077-1081.
13. Bucur B., Madden D.J., Spaniol J., Provenzale J.M., Cabeza R., White L.E., Huettel S.A. Age-related slowing of memory retrieval: contributions of perceptual speed and cerebral white matter integrity. Neurobiol. Aging 2008, 29:1070-1079.
14. Burggren A.C., Zeineh M.M., Ekstrom A.D., Braskie M.N., Thompson P.M., Small G.W., Bookheimer S.Y. Reduced cortical thickness in hippocampal subregions among cognitively normal apolipoprotein E e4 carriers. Neuroimage 2008, 41:1177-1183.
15. Burgmans S., van Boxtel M.P., Gronenschild E.H., Vuurman E.F., Hofman P., Uylings H.B., Jolles J., Raz N. Multiple indicators of age-related differences in cerebral white matter and the modifying effects of hypertension. Neuroimage 2010, 49:2083-2093.
16. Caselli R.J., Reiman E.M., Osborne D., Hentz J.G., Baxter L.C., Hernandez J.L., Alexander G.G. Longitudinal changes in cognition and behavior in asymptomatic carriers of the APOE e4 allele. Neurology 2004, 62:1990-1995.
17. Caselli R.J., Reiman E.M., Locke D.E., Hutton M.L., Hentz J.G., Hoffman-Snyder C., Woodruff B.K., Alexander G.E., Osborne D. Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment. Arch. Neurol. 2007, 64:1306-1311.
18. Charlton R.A., Barrick T.R., McIntyre D.J., Shen Y., O'Sullivan M., Howe F.A., Clark C.A., Morris R.G., Markus H.S. White matter damage on diffusion tensor imaging correlates with age-related cognitive decline. Neurology 2006, 66:217-222.
19. Charlton R.A., Landau S., Schiavone F., Barrick T.R., Clark C.A., Markus H.S., Morris R.G. A structural equation modeling investigation of age-related variance in executive function and DTI measured white matter damage. Neurobiol. Aging 2008, 29:1547-1555.
20. Cherbuin N., Leach L.S., Christensen H., Anstey K.J. Neuroimaging and APOE genotype: a systematic qualitative review. Dement. Geriatr. Cogn. Disord. 2007, 24:348-362.
21. Cho H., Yang D.W., Shon Y.M., Kim B.S., Kim Y.I., Choi Y.B., Lee K.S., Shim Y.S., Yoon B., Kim W., Ahn K.J. Abnormal integrity of corticocortical tracts in mild cognitive impairment: a diffusion tensor imaging study. J. Korean Med. Sci. 2008, 23:477-483.
22. Choi S.J., Lim K.O., Monteiro I., Reisberg B. Diffusion tensor imaging of frontal white matter microstructure in early Alzheimer's disease: a preliminary study. J. Geriatr. Psychiatry Neurol. 2005, 18:12-19.
23. Davidson Y., Gibbons L., Pritchard A., Hardicre J., Wren J., Stopford C., Julien C., Thompson J., Payton A., Pickering-Brown S.M., Pendleton N., Horan M.A., Burns A., Purandare N., Lendon C.L., Neary D., Snowden J.S., Mann D.M. Apolipoprotein E epsilon4 allele frequency and age at onset of Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 2007, 23:60-66.
24. Deary I.J., Bastin M.E., Pattie A., Clayden J.D., Whalley L.J., Starr J.M., Wardlaw J.M. White matter integrity and cognition in childhood and old age. Neurology 2006, 66:505-512.
25. Delis D.C., Kramer J., Kaplan E., Ober B.A. The California Verbal Learning Test 1987, Psychological Corporation, San Antonio, TX.
26. den Heijer T., Oudkerk M., Launer L.J., van Duijn C.M., Hofman A., Breteler M.M. Hippocampal, amygdalar, and global brain atrophy in different apolipoprotein E genotypes. Neurology 2002, 59:746-748.
27. Ding B., Chen K.M., Ling H.W., Zhang H., Chai W.M., Li X., Wang T. Diffusion tensor imaging correlates with proton magnetic resonance spectroscopy in posterior cingulate region of patients with Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 2008, 25:218-225.
28. Etminan M., Gill S., Samii A. Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies. BMJ 2003, 327:128.
29. Fazekas F., Chawluk J.B., Alavi A., Hurtig H.I., Zimmerman R.A. MRI signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJNR 1987, 8:421-426.
30. Fellgiebel A., Müller M.J., Wille P., Dellani P.R., Scheurich A., Schmidt L.G., Stoeter P. Color-coded diffusion-tensor-imaging of posterior cingulate fiber tracts in mild cognitive impairment. Neurobiol. Aging 2005, 26:1193-1198.
31. Fellgiebel A., Dellani P.R., Greverus D., Scheurich A., Stoeter P., Müller M.J. Predicting conversion to dementia in mild cognitive impairment by volumetric and diffusivity measurements of the hippocampus. Psychiatry Res. 2006, 146:283-287.
32. Firbank M.J., Blamire A.M., Krishnan M.S., Teodorczuk A., English P., Gholkar A., Harrison R., O'Brien J.T. Atrophy is associated with posterior cingulate white matter disruption in dementia with Lewy bodies and Alzheimer's disease. Neuroimage 2007, 36:1-7.
33. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975, 12:189-198.
34. Furutani K., Harada M., Minato M., Morita N., Nishitani H. Regional changes of fractional anisotropy with normal aging using statistical parametric mapping (SPM). J. Med. Invest. 2005, 52:186-190.
35. Gerdes L.U., Klausen I.C., Sihm I., Faergeman O. Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations around the world. Genet. Epidemiol. 1992, 9:155-167.
36. Glisky E.L., Kong L.L. Do young and older adults rely on different processes in source memory tasks? A neuropsychological study. J. Exp. Psychol. Learn. Mem. Cogn. 2008, 34:809-822.
37. Glisky E.L., Rubin S.R., Davidson P.S. Source memory in older adults: an encoding or retrieval problem?. J. Exp. Psychol. Learn. Mem. Cogn. 2001, 27:1131-1146.
38. Good C.D., Johnsrude I.S., Ashburner J., Henson R.N., Friston K.J., Frackowiak R.S. A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 2001, 14:21-36.
39. Grieve S.M., Williams L.M., Paul R.H., Clark C.R., Gordon E. Cognitive aging, executive function, and fractional anisotropy: a diffusion tensor MR imaging study. AJNR Am. J. Neuroradiol. 2007, 28:226-235.
40. Hanyu H., Sakurai H., Iwamoto T., Takasaki M., Shindo H., Abe K. Diffusion-weighted MR imaging of the hippocampus and temporal white matter in Alzheimer's disease. J. Neurol. Sci. 1998, 156:195-200.
41. Hart R.P., Kwentus J.A., Wade J.B., Taylor J.R. Modified Wisconsin Card Sorting Test in elderly normal, depressed and demented patients. Clin. Neuropsychol. 1988, 2:49-56.
42. Head D., Buckner R.L., Shimony J.S., Williams L.E., Akbudak E., Conturo T.E., McAvoy M., Morris J.C., Snyder A.Z. Differential vulnerability of anterior white matter in nondemented aging with minimal acceleration in dementia of the Alzheimer type: evidence from diffusion tensor imaging. Cereb. Cortex 2004, 14:410-423.
43. Hixson J.E., Vernier D.T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J. Lipid Res. 1990, 31:545-548.
44. Hsu J.L., Leemans A., Bai C.H., Lee C.H., Tsai Y.F., Chiu H.C., Chen W.H. Gender differences and age-related white matter changes of the human brain: a diffusion tensor imaging study. Neuroimage 2008, 39:566-577.
45. Huang J., Friedland R.P., Auchus A.P. Diffusion tensor imaging of normal-appearing white matter in mild cognitive impairment and early Alzheimer disease: preliminary evidence of axonal degeneration in the temporal lobe. AJNR Am. J. Neuroradiol. 2007, 28:1943-1948.
46. Hugenschmidt C.E., Peiffer A.M., Kraft R.A., Casanova R., Deibler A.R., Burdette J.H., Maldjian J.A., Laurienti P.J. Relating imaging indices of white matter integrity and volume in healthy older adults. Cereb. Cortex 2008, 18:433-442.
47. Jak A.J., Houston W.S., Nagel B.J., Corey-Bloom J., Bondi M.W. Differential cross-sectional and longitudinal impact of APOE genotype on hippocampal volumes in nondemented older adults. Dement. Geriatr. Cogn. Disord. 2007, 23:382-389.
48. Jiang H., van Zijl P.C., Kim J., Pearlson G.D., Mori S. DtiStudio: resource program for diffusion tensor computation and fiber bundle tracking. Comput. Meth. Programs Biomed. 2006, 81:106-116.
49. Jofre-Monseny L., Minihane A.M., Rimbach G. Impact of apoE genotype on oxidative stress, inflammation and disease risk. Mol. Nutr. Food Res. 2008, 52:131-145.
50. Kantarci K., Jack C.R., Xu Y.C., Campeau N.G., O'Brien P.C., Smith G.E., Ivnik R.J., Boeve B.F., Kokmen E., Tangalos E.G., Petersen R.C. Mild cognitive impairment and Alzheimer disease: regional diffusivity of water. Radiology 2001, 219:101-107.
51. Kantarci K., Petersen R.C., Boeve B.F., Knopman D.S., Weigand S.D., O'Brien P.C., Shiung M.M., Smith G.E., Ivnik R.J., Tangalos E.G., Jack C.R. DWI predicts future progression to Alzheimer disease in amnestic mild cognitive impairment. Neurology 2005, 64:902-904.
52. Kennedy K.M., Raz N. Aging white matter and cognition: differential effects of regional variations in diffusion properties on memory, executive functions, and speed. Neuropsychologia 2009, 47:916-927.
53. Kochunov P., Thompson P.M., Lancaster J.L., Bartzokis G., Smith S., Coyle T., Royall D.R., Laird A., Fox P.T. Relationship between white matter fractional anisotropy and other indices of cerebral health in normal aging: tract-based spatial statistics study of aging. Neuroimage 2007, 35:478-487.
54. Le Bihan D. Looking into the functional architecture of the brain with diffusion MRI. Nat. Rev. Neurosci. 2003, 4:469-480.
55. Lemaitre H., Crivello F., Dufouil C., Grassiot B., Tzourio C., Alperovitch A., Mazoyer B. No epsilon4 gene dose effect on hippocampal atrophy in a large MRI database of healthy elderly subjects. Neuroimage 2005, 24:1205-1213.
56. Ludwin S.K. The pathobiology of the oligodendrocyte. J. Neuropathol. Exp. Neurol. 1997, 56:111-124.
57. Madden D.J., Whiting W.L., Huettel S.A., White L.E., MacFall J.R., Provenzale J.M. Diffusion tensor imaging of adult age differences in cerebral white matter: relation to response time. Neuroimage 2004, 21:1174-1181.
58. Madden D.J., Spaniol J., Whiting W.L., Bucur B., Provenzale J.M., Cabeza R., White L.E., Huettel S.A. Adult age differences in the functional neuroanatomy of visual attention: a combined fMRI and DTI study. Neurobiol. Aging 2007, 28:459-476.
59. Mahley R.W., Rall S.C. Apolipoprotein E: far more than a lipid transport protein. Annu. Rev. Genomics Hum. Genet. 2000, 1:507-537.
60. Mahley R.W., Weisgraber K.H., Huang Y. Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proc. Natl Acad. Sci. USA 2006, 103:5644-5651.
61. Mayeux R., Small S.A., Tang M., Tycko B., Stern Y. Memory performance in healthy elderly without Alzheimer's disease: effects of time and apolipoprotein-E. Neurobiol. Aging 2001, 22:683-689.
62. McGeer P.L., Schulzer M., McGeer E.G. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology 1996, 47:425-432.
63. Medina D., Toledo-Morrell L., Urresta F., Gabrieli J.D., Moseley M., Fleischman D., Bennett D.A., Leurgans S., Turner D.A., Stebbins G.T. White matter changes in mild cognitive impairment and AD: A diffusion tensor imaging study. Neurobiol. Aging 2006, 27:663-672.
64. Mosconi L., De S.S., Brys M., Tsui W.H., Pirraglia E., Glodzik-Sobanska L., Rich K.E., Switalski R., Mehta P.D., Pratico D., Zinkowski R., Blennow K., de Leon M.J. Hypometabolism and altered cerebrospinal fluid markers in normal apolipoprotein E E4 carriers with subjective memory complaints. Biol. Psychiatry 2008, 63:609-618.
65. Müller M.J., Greverus D., Dellani P.R., Weibrich C., Wille P.R., Scheurich A., Stoeter P., Fellgiebel A. Functional implications of hippocampal volume and diffusivity in mild cognitive impairment. Neuroimage 2005, 28:1033-1042.
66. Naggara O., Oppenheim C., Rieu D., Raoux N., Rodrigo S., Dalla B.G., Meder J.F. Diffusion tensor imaging in early Alzheimer's disease. Psychiatry Res. 2006, 146:243-249.
67. Nierenberg J., Pomara N., Hoptman M.J., Sidtis J.J., Ardekani B.A., Lim K.O. Abnormal white matter integrity in healthy apolipoprotein E epsilon4 carriers. NeuroReport 2005, 16:1369-1372.
68. Nilsson L.G., Adolfsson R., Backman L., Cruts M., Nyberg L., Small B.J., Van B.C. The influence of APOE status on episodic and semantic memory: data from a population-based study. Neuropsychology 2006, 20:645-657.
69. Pagani E., Agosta F., Rocca M.A., Caputo D., Filippi M. Voxel-based analysis derived from fractional anisotropy images of white matter volume changes with aging. Neuroimage 2008, 41:657-667.
70. Persson J., Lind J., Larsson A., Ingvar M., Cruts M., Van B.C., Adolfsson R., Nilsson L.G., Nyberg L. Altered brain white matter integrity in healthy carriers of the APOE epsilon4 allele: a risk for AD?. Neurology 2006, 66:1029-1033.
71. Peters A. The effects of normal aging on myelin and nerve fibers: a review. J. Neurocytol. 2002, 31:581-593.
72. Peters A. The effects of normal aging on myelinated nerve fibers in monkey central nervous system. Front. Neuroanat. 2009, 10.3389/neuro.05.011.2009.
73. Pfefferbaum A., Adalsteinsson E., Sullivan E.V. Frontal circuitry degradation marks healthy adult aging: evidence from diffusion tensor imaging. Neuroimage 2005, 26:891-899.
74. Ray K.M., Wang H., Chu Y., Chen Y.F., Bert A., Hasso A.N., Su M.Y. Mild cognitive impairment: apparent diffusion coefficient in regional gray matter and white matter structures. Radiology 2006, 241:197-205.
75. Raz N., Rodrigue K.M., Kennedy K.M., Land S. Genetic and vascular modifiers of age-sensitive cognitive skills: effects of COMT, BDNF, ApoE, and hypertension. Neuropsychology 2009, 23:105-116.
76. Reiman E.M., Caselli R.J., Chen K., Alexander G.E., Bandy D., Frost J. Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: a foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease. Proc. Natl Acad. Sci. USA 2001, 98:3334-3339.
77. Reiman E.M., Chen K., Alexander G.E., Caselli R.J., Bandy D., Osborne D., Saunders A.M., Hardy J. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. Proc. Natl Acad. Sci. USA 2004, 101:284-289.
78. Reiman E.M., Chen K., Alexander G.E., Caselli R.J., Bandy D., Osborne D., Saunders A.M., Hardy J. Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism. Proc. Natl Acad. Sci. USA 2005, 102:8299-8302.
79. Reines S.A., Block G.A., Morris J.C., Liu G., Nessly M.L., Lines C.R., Norman B.A., Baranak C.C. Rofecoxib: no effect on Alzheimer's disease in a 1-year, randomized, blinded, controlled study. Neurology 2004, 62:66-71.
80. Rose S.E., Janke A.L., Chalk J.B. Gray and white matter changes in Alzheimer's disease: a diffusion tensor imaging study. J. Magn. Reson. Imaging 2008, 27:20-26.
81. Salat D.H., Tuch D.S., Greve D.N., van der Kouwe A.J., Hevelone N.D., Zaleta A.K., Rosen B.R., Fischl B., Corkin S., Rosas H.D., Dale A.M. Age-related alterations in white matter microstructure measured by diffusion tensor imaging. Neurobiol. Aging 2005, 26:1215-1227.
82. Sando S.B., Melquist S., Cannon A., Hutton M.L., Sletvold O., Saltvedt I., White L.R., Lydersen S., Aasly J.O. APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from central Norway. BMC Neurol. 2008, 8:9.
83. Scarmeas N., Stern Y. Imaging studies and APOE genotype in persons at risk for Alzheimer's disease. Curr. Psychiatry Rep. 2006, 8:11-17.
84. Scharf S., Mander A., Ugoni A., Vajda F., Christophidis N. A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimer's disease. Neurology 1999, 53:197-201.
85. Schultz M.R., Lyons M.J., Franz C.E., Grant M.D., Boake C., Jacobson K.C., Xian H., Schellenberg G.D., Eisen S.A., Kremen W.S. Apolipoprotein E genotype and memory in the sixth decade of life. Neurology 2008, 70:1771-1777.
86. Shenkin S.D., Bastin M.E., MacGillivray T.J., Deary I.J., Starr J.M., Wardlaw J.M. Childhood and current cognitive function in healthy 80-year-olds: a DT-MRI study. NeuroReport 2003, 14:345-349.
87. Shenkin S.D., Bastin M.E., MacGillivray T.J., Deary I.J., Starr J.M., Rivers C.S., Wardlaw J.M. Cognitive correlates of cerebral white matter lesions and water diffusion tensor parameters in community-dwelling older people. Cerebrovasc. Dis. 2005, 20:310-318.
88. Small G.W., Ercoli L.M., Silverman D.H., Huang S.C., Komo S., Bookheimer S.Y., Lavretsky H., Miller K., Siddarth P., Rasgon N.L., Mazziotta J.C., Saxena S., Wu H.M., Mega M.S., Cummings J.L., Saunders A.M., Pericak-Vance M.A., Roses A.D., Barrio J.R., Phelps M.E. Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proc. Natl Acad. Sci. USA 2000, 97:6037-6042.
89. Small B.J., Rosnick C.B., Fratiglioni L., Backman L. Apolipoprotein E and cognitive performance: a meta-analysis. Psychol. Aging 2004, 19:592-600.
90. Smith C.D., Chebrolu H., Andersen A.H., Powell D.A., Lovell M.A., Xiong S., Gold B.T. White matter diffusion alterations in normal women at risk of Alzheimer's disease. Neurobiol. Aging. 2008, 10.1016/j.neurobiolaging.2008.08.006.
91. Song S.K., Sun S.W., Ramsbottom M.J., Chang C., Russell J., Cross A.H. Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water. Neuroimage 2002, 17:1429-1436.
92. Spreen O., Benton A.L. Neurosensory Center Comprehensive Examination for Aphasia 1977, University of Victoria Neuropsychology Laboratory, Victoria, British Columbia, Canada. Revised Edition.
93. Stahl R., Dietrich O., Teipel S.J., Hampel H., Reiser M.F., Schoenberg S.O. White matter damage in Alzheimer disease and mild cognitive impairment: assessment with diffusion-tensor MR imaging and parallel imaging techniques. Radiology 2007, 243:483-492.
94. Sullivan E.V., Pfefferbaum A. Diffusion tensor imaging and aging. Neurosci. Biobehav. Rev. 2006, 30:749-761.
95. Sullivan E.V., Adalsteinsson E., Pfefferbaum A. Selective age-related degradation of anterior callosal fiber bundles quantified in vivo with fiber tracking. Cereb. Cortex 2006, 16:1030-1039.
96. Swan G.E., Lessov-Schlaggar C.N., Carmelli D., Schellenberg G.D., La Rue A. Apolipoprotein E epsilon4 and change in cognitive functioning in community-dwelling older adults. J. Geriatr. Psychiatry Neurol. 2005, 18:196-201.
97. Sydykova D., Stahl R., Dietrich O., Ewers M., Reiser M.F., Schoenberg S.O., Moller H.J., Hampel H., Teipel S.J. Fiber connections between the cerebral cortex and the corpus callosum in Alzheimer's disease: a diffusion tensor imaging and voxel-based morphometry study. Cereb. Cortex 2007, 17:2276-2282.
98. Szekely C.A., Thorne J.E., Zandi P.P., Ek M., Messias E., Breitner J.C., Goodman S.N. Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review. Neuroepidemiology 2004, 23:159-169.
99. Teipel S.J., Stahl R., Dietrich O., Schoenberg S.O., Perneczky R., Bokde A.L., Reiser M.F., Moller H.J., Hampel H. Multivariate network analysis of fiber tract integrity in Alzheimer's disease. Neuroimage 2007, 34:985-995.
100. Walther K., Bendlin B.B., Glisky E.L., Trouard T.P., Lisse J.R., Posever J.O., Ryan L. Anti-inflammatory drugs reduce age-related decreases in brain volume in cognitively normal older adults. Neurobiol. Aging. 2009, 10.1016/j.neurobiolaging.2009.03.006.
101. Wechsler D. Wechsler Adult Intelligence Scale-Revised 1981, Psychological Corporation, New York.
102. Wechsler D. Wechsler Memory Scale-Revised 1987, Psychological Corporation, New York.
103. Wechsler D. Wechsler Memory Scale-III 1997, Psychological Corporation, San Antonio, TX.
104. Wechsler D. Wechsler Abbreviated Scale of Intelligence (WASI) 1999, Psychological Corporation, San Antonio.
105. Wishart H.A., Saykin A.J., McAllister T.W., Rabin L.A., McDonald B.C., Flashman L.A., Roth R.M., Mamourian A.C., Tsongalis G.J., Rhodes C.H. Regional brain atrophy in cognitively intact adults with a single APOE epsilon4 allele. Neurology 2006, 67:1221-1224.
106. Xie S., Xiao J.X., Gong G.L., Zang Y.F., Wang Y.H., Wu H.K., Jiang X.X. Voxel-based detection of white matter abnormalities in mild Alzheimer disease. Neurology 2006, 66:1845-1849.
107. Yasmin H., Nakata Y., Aoki S., Abe O., Sato N., Nemoto K., Arima K., Furuta N., Uno M., Hirai S., Masutani Y., Ohtomo K. Diffusion abnormalities of the uncinate fasciculus in Alzheimer's disease: diffusion tensor tract-specific analysis using a new method to measure the core of the tract. Neuroradiology 2008, 50:293-299.
108. Zhang Y.T., Zhang C.Y., Zhang J., Li W. Age-related changes of normal adult brain structure: analysed with diffusion tensor imaging. Chin. Med. J. (Engl.) 2005, 118:1059-1065.
109. Zhang Y., Schuff N., Jahng G.H., Bayne W., Mori S., Schad L., Mueller S., Du A.T., Kramer J.H., Yaffe K., Chui H., Jagust W.J., Miller B.L., Weiner M.W. Diffusion tensor imaging of cingulum fibers in mild cognitive impairment and Alzheimer disease. Neurology 2007, 68:13-19.
110. Zhang Y., Du A.T., Hayasaka S., Jahng G.H., Hlavin J., Zhan W., Weiner M.W., Schuff N. Patterns of age-related water diffusion changes in human brain by concordance and discordance analysis. Neurobiol. Aging. 2008, 10.1016/j.neurobiolaging.2008.10.009.